Clinical Trials
29 trialsCOVAR
Institut Curie
Care Plans for Cancer Predisposition
Children's Hospital of Philadelphia
Bundled Cancer Screening and Genetic Services Navigation
Georgetown University
MRIMOP
University Hospital, Montpellier
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Dana-Farber Cancer Institute
MyeloGen
Dana-Farber Cancer Institute
PRE-PDAC
Catholic University of the Sacred Heart
EX²TRICAN
Centre Georges Francois Leclerc
IMPACT
Institute of Oncology Ljubljana
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
Dana-Farber Cancer Institute
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
PTX3AML
Centre Hospitalier Universitaire Vaudois
BRIDGEScohort2
Institut Curie
Genetic Information Assistant in Telegenetics
University of Virginia
CANHPARI
Assistance Publique - Hôpitaux de Paris
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
EXOCARE
University Hospital, Angers
MyCancerGene
Abramson Cancer Center at Penn Medicine
RNSM
University Health Network, Toronto
Early Detection of GEnetic Risk (EDGE)
University of Washington
Family History Study on Cancer Risk
Kaiser Permanente
GE-MED
University Hospital Tuebingen
IonGER
University Hospital Tuebingen
FPG-500
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PROPH-ITA
Associazione Italiana per lo Studio del Pancreas
ProFam-Risk
Heinrich-Heine University, Duesseldorf
Family History and Breast Cancer Education Trial
State University of New York at Buffalo
Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)
CHU de Reims
REACH
University of Utah